Finally, (3) the results of this study suggest that future clinical trials evaluating the predictive significance of TS expression in colon cancer for 5FU-based adjuvant chemotherapy should take the p21WAF1/p53 immunophenotype of the tumor cells into account. The gene discussed is TYMS; the disease is malignant colon neoplasm.